Current models of lymphocyte activation suggest that formation of a signaling complex, or signalosome', composed of Syk, Bruton's tyrosine kinase (Btk), phospholipase g2 and the adaptor protein B cell linker protein (BLNK) is critical for transmission of signals from the BCR. However, impaired B cell development in mice lacking each individual signalosome component has made it dif®cult to study the functional consequences of the formation of this complex in mature B cells. Sensitized genetic systems, commonly used in Drosophila, de®ne signaling pathways by combining partial loss of function mutations in the components of interest. This allows genetic interactions to be observed in the absence of pleiotropic or lethal effects of complete de®ciency of either gene. We used this approach to demonstrate that Btk and BLNK are limiting components of a common signaling pathway that mediates the mitogenic response of mature B cells to antigen. B cells from transgenic mice expressing a limiting dosage of Btk (Btk lo ) have normal numbers of mature B cells that have reduced, but measurable, responses to BCR cross-linking. Haploinsuf®ciency of BLNK did not affect the development of Btk lo B cells. However, it exacerbated their defects in BCR-induced Ca 2+¯u x, IkB degradation, and up-regulation of cyclin D2, bcl-x L and A1 leading to dramatic impairment of B cell mitogenic responses. In contrast, no effect of reduced Btk and BLNK dosage was observed on extracellular signal-regulated kinase activation. These results suggest that the signals regulating the maintenance and activation of mature B cells are differentially sensitive to the strength of the signal emanating from the signalosome.
Introduction
Signals from the BCR are critical at multiple stages of the development and function of a self-tolerant, diverse repertoire of B lymphocytes. The outcome of these signals varies and can include proliferation, differentiation, survival, apoptosis, anergy or receptor editing. Factors affecting the response to BCR stimulation include the maturity of the recipient cell, the strength and duration of the signal, and the presence or absence of additional signals from co-receptors, cytokines or T cell help (1) . BCR signals are initiated by the activation of three families of tyrosine kinases: Src family kinases including Lyn, Fyn and Blk, the Tec family kinase Bruton's tyrosine kinase (Btk), and Syk (2±5). The formation of a signaling complex, or`signalosome', in which the adaptor protein B cell linker protein (BLNK) allows tyrosine kinases access to critical substrates has recently been proposed as a major step in BCR signal transduction (6, 7) . According to this model, BLNK is phosphorylated by Syk in response to BCR cross-linking (8, 9) . The Src homology 2 (SH2) domains of Btk and phospholipase C (PLC) g2 are then recruited to phosphorylated BLNK, allowing Syk and Btk to phosphorylate and activate PLCg2 (8±11). Activated PLCg2 cleaves phosphatidylinositol-4,5-bisphosphate into inositol-1,4,5-trisphosphate and diacyglycerol, leading to Ca 2+ mobilization, activation of protein kinase C (PKC) b, and eventual changes in gene expression mediated by transcription factors such as NF-kB and NF-AT (2±5). Among the genes up-regulated in response to BCR crosslinking include those controlling cell cycle entry, such as cyclin D2 (12) , and cell survival, including bcl-x L (13) and A1 (14) .
Biochemical studies support the signalosome model but suggest that Btk and BLNK may also have independent functions. Physical interactions between BLNK, PLCg2 (8) and Btk (11) have been demonstrated in vitro. Overexpression experiments in 293 cells have shown that optimal phosphorylation of PLCg2 by Syk and Btk requires the presence of BLNK (11) . This approach has also suggested that BLNK mediates the activation of Btk by Syk (15) , although BCR-induced tyrosine phosphorylation of Btk is normal in BLNK ±/± murine B cells (16) . However, BLNK can also physically associate with a number of other signaling molecules, including growth factor receptor-binding protein (Grb2), Vav and Nck (8) that are not necessarily involved in the regulation of the Btk/PLCg2 pathway. Btk has been shown to interact with or phosphorylate a number of transcription factors, including transcription factor II-I (17), STAT-5a (18) and BRIGHT (19) . None of these interactions have been shown to require BLNK.
B cells de®cient in signalosome components also reveal both overlapping and separate functions for these molecules. BCR-stimulated PLCg2 activation and Ca 2+¯u x are defective in BLNK ±/± (9), Syk ±/± (20) and Btk ±/± (21,22) chicken DT40 cells, and reduced in B cells from BLNK ±/± (16, 23, 24) and Xlinked immunode®ciency (xid) (25) mice or Btk-de®cient humans (26) . However, in the chicken system BCR-mediated activation of extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 requires BLNK (9), while Btk is absolutely necessary only for JNK activation (27) .
Finally, in vivo genetic analysis also demonstrates a complex interaction between Btk and BLNK. xid mice, which have a naturally occurring point mutation in Btk (28, 29) , and mice de®cient in Btk (30±32), PLCg2 (33, 34) or BLNK (23, 24, 35, 36) all have a block in B cell development at the immature to mature transition in the periphery. Impaired responses to Tindependent type II antigens, reduced numbers of CD5 + B-1 cells and failure of B cells to proliferate in response to BCR cross-linking are also shared features of these mice (6) . Humans with mutations in BLNK have a severe B cell immunode®ciency (37) resembling X-linked agammaglobulinemia (XLA), which results from loss of Btk function (38, 39) . The striking similarity of these phenotypes suggests that these molecules regulate similar pathways and processes in B cell development and function. However, unlike Btk ±/± mice, BLNK ±/± mice also have a block in B lymphopoiesis at the pro-B to pre-B stage (23, 24, 35, 36) . This is also observed in Syk ±/± mice (40, 41) , suggesting that at least some B cell signalosome components mediate pre-BCR signals as well (42) . Formal genetic proof of independent roles for Btk and BLNK comes from the demonstration that mice lacking both genes have more profound defects than either Btk ±/± or BLNK ±/± mice alone (43) .
The developmental block in mice lacking Btk, BLNK or both has precluded analysis of whether these molecules function in concert or independently to mediate the activation of mature primary B cells. The well-documented differences in the consequences of BCR stimulation between immature and mature mammalian B cells (44, 45) , and the differential effects of BLNK de®ciency on BCR signaling in chicken and murine B cells (9, 16) limit the extrapolation of results in these systems to mature B lymphocytes. We therefore used a sensitized genetic system analogous to those commonly used in Drosophila (46) to assess the functional consequences of the interaction between Btk and BLNK. This approach de®nes signaling pathways by combining partial loss of function mutations in the components of interest, allowing genetic interactions to be observed in the absence of pleiotropic or lethal effects of complete de®ciency of either gene.
We have previously employed this strategy to de®ne functional interactions between Btk and its upstream regulators (47) . Unlike xid or Btk ±/± mice, mice expressing a limiting dosage of Btk (Btk lo ) have normal numbers of phenotypically mature B cells (48) . These cells display an intermediate proliferative response to BCR cross-linking between that of wild-type and Btk ±/± B cells (48) . The mitogenic response of Btk lo B cells was shifted towards wild-type by mutations in Lyn, SH2-containing inositol phosphatase or phosphatase and tensin homolog, de®ning these genes as negative regulators of Btk signaling pathways (47) . In this report, we demonstrate that haploinsuf®ciency of BLNK enhances the signaling defects of Btk lo B cells without affecting their development. Thus, Btk and BLNK interact functionally to mediate the responses of mature B cells to BCR stimulation.
Methods

Mice
Btk lo mice are Btk ±/± mice carrying a wild-type Btk transgene driven by the Ig heavy chain promoter and enhancer (48) . BLNK +/± (23) mice were mated to Btk lo mice to generate progeny of the appropriate genotypes. Since Btk is X-linked and the mutant allele is inactivated in mature B cells of carrier females (49) , Btk +/± and Btk +/+ mice were used interchangeably. All mice were between 6 and 12 weeks of age. Since mice were of mixed genetic background (C57BL/6 Q 129 Q BALB/c), littermates were compared directly when possible and experiments were repeated with multiple litters. Mice were genotyped by PCR.
Flow cytometry
Splenocytes were depleted of red blood cells by 5 min incubation in 0.15 M NH 4 Cl, 1 mM KHCO 3 and 0.1 mM Na 2 EDTA, and stained with combinations of anti-IgD±FITC (PharMingen, San Diego, CA), anti-CD21±FITC (PharMingen), anti-IgM±phycoerythrin (PE) (PharMingen), anti-B220±TriColor (Caltag, Burlingame, CA), anti-B220±PerCP (PharMingen) and anti-CD23±biotin (PharMingen) plus streptavidin±allophyco-cyanin (Caltag). Samples were run on a Becton Dickinson (San Jose, CA) FACSCalibur and analyzed with CellQuest software.
B cell puri®cation
Splenic B cells were puri®ed by negative selection with anti-CD43 magnetic beads using the Miltenyi (Auburn, CA) MidiMACS system according to the manufacturer's instructions. The puri®ed cells were typically >90% B220 + as measured by¯ow cytometry as described above.
Proliferation assays
Puri®ed B cells were plated in 96-well plates at 10 6 /ml in RPMI + 10% FCS. Triplicate wells were used for each stimulation condition. Stimulation conditions included media alone, 20 mg/ ml goat anti-mouse IgM F(ab¢) 2 fragments (Jackson ImmunoResearch, West Grove, PA), and 10 ng/ml phorbol myristate acetate (Sigma, St Louis, MO) + 1 mg/ml ionomycin (Calbiochem, San Diego, CA). Cells were incubated at 37% in a humidi®ed incubator for 48 h. 1 mCi 
Cell cycle analysis
Puri®ed B cells were plated in 48-well plates at 10 6 /ml in RPMI + 10% FCS and stimulated with 20 mg/ml goat anti-mouse IgM F(ab¢) 2 fragments (Jackson ImmunoResearch) for 48 h. Cells were ®xed in 70% EtOH for 24 h and subsequently stained with 80 mg/ml propidium iodide in the presence of 250 mg/ml RNase A. Samples were run on a FACScan (Becton Dickinson) and analyzed with CellQuest software (Becton Dickinson).
Immunoblot analysis
For BLNK and Btk expression and cyclin D2 and bcl-x L upregulation, puri®ed B cells were harvested at time 0 or stimulated with 10 mg/ml goat anti-mouse IgM F(ab¢) 2 fragments (Jackson ImmunoResearch) for 18 h. Cells were washed in PBS and resuspended in 50 ml ice-cold lysis buffer (10 mM Tris, pH 7.5, 150 mM NaCl, 1% Triton X-100 and 0.5 mM PMSF) per 10 7 cells. Extracts were spun at maximum speed in a refrigerated microfuge to remove insoluble material. For IkB degradation studies, puri®ed B cells were treated with 50 nM cycloheximide (Sigma) for 30 min at 37°C. Cells were then stimulated for 4 h at 37°C in the continued presence of cycloheximide with either no additional treatment or 10 mg/ml goat anti-mouse IgM F(ab¢) 2 fragments (Jackson Immuno Research). Cytoplasmic extracts were prepared by washing cells in PBS and resuspending them in 100 ml Buffer A (10 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT, 0.2 mM PMSF, 10 mM iodoacetamide, 1 mg/ml pepstatin A and 1 mg/ml aprotinin) per 2±4 Q 10 7 cells. Samples were incubated on ice for 10 min, vortexed for 10 s and spun at maximum speed for 10 s in a microfuge to remove nuclei. The supernatant was collected as the cytoplasmic fraction. For ERK activation, puri®ed B cells were resuspended at 10 8 /ml in serum-free media and stimulated with 0 or 10 mg/ml goat antimouse IgM F(ab¢) 2 fragments (Jackson ImmunoResearch) for 5 min. Cells were lysed by boiling in SDS sample buffer for 10 min.
Total cell extracts (6 mg, 20 mg or 2 Q 10 6 cell equivalents) were electrophoresed by 10 or 12% SDS±PAGE gels and blotted to nitrocellulose. Blots were blocked in 5% milk in 10 mM Tris, pH 7.5 and 150 mM NaCl, and subsequently probed with anti-BLNK (9), anti-Btk (38), anti-cyclin D2 (Santa Cruz Biotechnologies, Santa Cruz, CA), anti-bcl-x L (Santa Cruz Biotechnologies), anti-IkBa (Santa Cruz Biotechnologies), anti-pERK (Cell Signaling Technologies, Beverley, MA), anti-ERK (Cell Signaling Technologies) or anti-actin (Sigma) diluted in 10 mM Tris, pH 7.5, 250 mM NaCl, 0.05% Tween 20 and 0.2% sodium azide. Blots were washed in 10 mM Tris, pH 7.5, 500 mM NaCl and 0.05% Tween 20, and then incubated with horseradish peroxidase-conjugated goat antimouse Ig (bcl-x L , actin and BLNK) (Bio-Rad, Hercules, CA) or goat anti-rabbit Ig (Btk, cyclin D2, IkBa, pERK and ERK) (BioRad) diluted in 10 mM Tris, pH 7.5, 250 mM NaCl and 0.05% Tween 20. Blots were washed in 10 mM Tris, pH 7.5, 500 mM NaCl and 0.05% Tween 20, and horseradish peroxidase subsequently visualized using an ECL kit (Amersham).
Real time quantitative RT-PCR
Puri®ed B cells were harvested at time 0 or stimulated with 10 mg/ml goat anti-mouse IgM F(ab¢) 2 fragments (Jackson ImmunoResearch) for 1 h. Total RNA was obtained using TRIzol (Gibco/BRL, Carlsbad, CA) according to the manufacturer's instructions. Contaminating genomic DNA was removed by treatment with RNase-free DNase (Gibco/BRL). cDNA was prepared using Superscript II reverse transcriptase (Gibco/BRL) and random hexamers. Real-time PCR was performed in an Applied Biosystems (Foster City, CA) Gene Amp 5700 Sequence Detection System using ABI Prism optical tubes. Reactions were performed in triplicate in a total volume of 20 ml that included 10 ng cDNA, 10 ml SyBR Green master mix (Applied Biosystems) and 200 nM of each primer. Primer sequences are as follows. A1: 5¢-CAA ATC TGG CTG GCT GAC TTT TC-3¢ and 5¢-CAA GTG CTG ATA ACC ATT CTC GTC-3¢ (50); actin: 5¢-GAG GCC CAG AGC AAG AGA G-3¢ and 5¢-GTC ATC TTT TCA CGG TTG G-3¢. Standard curves were generated for each primer set using serial dilutions of cDNA from stimulated wild-type cells. The relative amount of A1 cDNA in each sample was calculated based on the standard curve, then normalized to the amount of actin to control for cDNA loading.
Ca 2+¯u x
Puri®ed B cells were resuspended in loading buffer (HBSS + 10 mM HEPES, pH 7.2, 2mM CaCl 2 , 1 mM MgCl 2 and 1% BSA) at 5 Q 10 6 /ml and loaded with 5 mM Fluo-4-AM (Molecular Probes, Eugene, OR) in the presence of 0.2 mg/ml Pluronic F-127 (Molecular Probes) for 30 min at 37°C. Cells were washed and resuspended in loading buffer at 5 Q 10 6 /ml. Cells were prewarmed to 37°C for 5 min. and maintained at 37°C throughout the analysis. Cells were plated at 10 6 cells/well in a black 96-well plate with a clear bottom (Corning, Corning, NY), with triplicate wells per sample. Baseline Fluo-4¯uores-cence (a measure of intracellular Ca 2+ levels) was read at 10-s intervals for 1 min in an FLx800 microplate¯uorescence reader (BioTek, Winooski, VT). Goat anti-mouse IgM F(ab¢) 2 fragments (Jackson ImmunoResearch) were then added to a ®nal concentration of 20 mg/ml. Fluo-4¯uorescence was measured at 10-s intervals for an additional 5 min. 
Results
To obtain B cells with reduced dosage of Btk, BLNK or both, we crossed Btk lo mice to BLNK +/± mice. This resulted in progeny of the following genotypes: wild-type, Btk lo , Btk ±/± , BLNK +/± , BLNK +/± Btk lo and BLNK +/± Btk ±/± . Puri®ed splenic B cells from each type of mouse were subjected to immunoblot analysis to ensure that Btk and BLNK were expressed at the expected levels (Fig. 1) . BLNK +/± B cells had about half of the amount of BLNK as BLNK +/+ mice regardless of the amount of Btk they expressed. Similarly, expression of Btk from either the endogenous gene or the transgene was independent of BLNK.
Both BLNK and Btk are required for the immature to mature B transition in the periphery (23,24,30±32,35,36) . We therefore asked whether partial loss of function of either or both genes would also impair this developmental process. Mature IgM lo IgD hi B cells were present at similar relative frequencies and absolute numbers in BLNK +/± , Btk lo and BLNK +/± Btk lo mice ( Fig. 2A and B) (48) . We also did not observe any differences in the frequency of marginal zone, T1, T2 or mature B cells between wild-type and BLNK +/± Btk lo mice as measured by CD21, CD23 and IgM expression (Fig. 2C) .
Both BLNK +/± and Btk lo B cells can proliferate upon BCR cross-linking, although their response is reduced relative to that of wild-type B cells (Fig. 3) (48) . To determine whether Btk and BLNK work together to transmit this mitogenic signal, the proliferative response of B cells with reduced dosage of both genes was assessed. BLNK +/± Btk lo B cells did not respond to BCR cross-linking, thus resembling Btk ±/± B cells. This was not due a general inability to enter the cell cycle, as BLNK +/± Btk lo B cells responded as well as or better than wild-type cells to phorbol myristate acetate + ionomycin (Fig. 3A) . To assess whether the failure of BLNK +/± Btk lo B cells to proliferate upon BCR stimulation was due to defects in cell survival, entry into S phase or both, we performed cell cycle analysis on B cells stimulated for 48 h with 20 mg/ml anti-IgM (Fig. 3B) . Btk lo and BLNK +/± B cells each displayed a reduced frequency of cycling cells and an increased percentage of cells with a <2n DNA content indicative of increased cell death. Both defects were further exacerbated in BLNK +/± Btk lo B cells. Thus, Btk and BLNK work together to regulate both survival and proliferation of BCR-stimulated B cells. These results are consistent with observations made in the relatively immature B cells from Btk ±/± (Fig. 3B) , xid (51, 52) and BLNK ±/± (16) mice.
This type of genetic experiment alone cannot determine whether Btk and BLNK are components of the same pathway or parallel, independent pathways mediating BCR-induced proliferation. The former possibility predicts that downstream signaling events partially impaired in Btk lo B cells would be further decreased in BLNK +/± Btk lo B cells, while the latter Fig. 1 . Expression of Btk and BLNK are independent of each other. Whole-cell extracts (20 mg) prepared from puri®ed splenic B cells were electrophoresed on a 10% SDS±PAGE gel, blotted to nitrocellulose, and probed sequentially with anti-Btk, anti-BLNK and anti-actin antibodies. implies that events sensitive to reduced Btk dosage would not be affected by the heterozygous mutation in BLNK. Previous reports have shown that B cells from xid, Btk ±/± and BLNK ±/± mice fail to up-regulate bcl-x L and cyclin D2 upon BCR crosslinking (16,51±53). It is not clear, however, whether the impaired activation of these pathways results from the immaturity of Btk-or BLNK-de®cient B cells or a requirement for Btk and BLNK per se to transmit the BCR signal. We therefore assessed the expression of these genes in Btk lo , BLNK +/± and BLNK +/± Btk lo B cells, which are phenotypically mature (Fig. 2)  (48) . BCR stimulated expression of bcl-x L and cyclin D2 occurred in Btk lo and BLNK +/± B cells, but to a lesser degree than was observed in wild-type B cells (Fig. 4A) . This is consistent with the partial defects in proliferative response and survival of these cells (Fig. 3) . BLNK +/± Btk lo B cells resembled Btk ±/± B cells in their failure to induce either of these genes in response to BCR cross-linking. The increased level of bcl-x L in unstimulated Btk ±/± B cells is consistent with their immature phenotype (13) .
Both cyclin D2 and bcl-x L are up-regulated relatively late after BCR stimulation. To assess the effect of the B cell signalosome on the regulation of early response genes, we chose the bcl-2 family member A1 as a representative example. This gene was of particular interest for several reasons. A1 can protect B cells from BCR-induced apoptosis (14) , which is increased in xid and BLNK ±/± B cells (16, 51) . Its expression is regulated by c-rel (14) and calcium-dependent signals from the BCR (54), both of which are impaired in xid (25, 55, 56) and BLNK ±/± (16,23,24 ) B cells. Therefore we used real-time quantitative RT-PCR to assess the dependence of BCR-induced up-regulation of A1 on Btk and BLNK. Like cyclin D2 and bcl-x L , A1 induction was attenuated in Btk lo and BLNK +/± B cells, and almost completely impaired by reduced dosage of both genes (Fig. 4b) .
A major function of the B cell signalosome is to regulate BCR-induced Ca 2+¯u x (6,7). In primary mouse B cells, in¯ux of extracellular Ca 2+ is required for BCR-stimulated upregulation of A1 (54) and cyclin D2 (57) . We therefore assessed the effect of reduced Btk and/or BLNK levels on 4 . BCR-stimulated up-regulation of cyclin D2, bcl-x L and A1 expression is mediated by BLNK and Btk. (A) Whole-cell extracts were prepared from splenic B cells puri®ed from pools of two or three mice per genotype and stimulated with 10 mg/ml anti-IgM F(ab¢) 2 fragments for 18 h. Then 20 mg of extract was electrophoresed on a 12% SDS±PAGE gel, blotted to nitrocellulose, and probed consecutively with anti-cyclin D2, anti-bcl-x L and antiactin antibodies. These results are representative of three independent experiments. (B) cDNA was prepared from splenic B cells puri®ed from pools of two or three mice per genotype and stimulated with 10 mg/ml anti-IgM F(ab¢) 2 fragments for 0 or 1 h. Real-time PCR was performed in triplicate with primers for either A1 or actin. Standard curves were generated for each primer set using serial dilutions of cDNA from stimulated wild-type cells. The relative amount of A1 cDNA in each sample was calculated based on the standard curve, then normalized to the amount of actin to control for cDNA loading. Data are the mean of triplicate samples T SD and are representative of two independent experiments. (Fig. 5A) . BLNK +/± B cells had relatively normal responses, while reduced dosage of Btk led to a small decrease in the peak Ca 2+ level during the initial¯ux. The latter result is consistent with observations made in B cells from Btk ±/± mice (58) . A more pronounced effect was observed in BLNK +/± Btk lo cells, with lower than normal responses during both the early and late phases of Ca 2+ mobilization.
Activation of the NF-kB pathway is downstream of both major signals regulated by the B cell signalosome, Ca 2+¯u x (59) and PKCb activation (60) . c-rel, a member of the NF-kB family, is required for A1 (14) and bcl-x L transcription (61±63).
NF-kB activation requires degradation of IkB, which is impaired in BCR-stimulated immature B cells from both Btk ±/± (55, 56) and BLNK ±/± (16) mice. Taken together, these observations predict that BLNK +/± Btk lo B cells will demonstrate decreased IkB degradation in response to BCR cross-linking compared to Btk lo or BLNK +/± B cells. Indeed, a partial inhibition of IkBa degradation was observed in both Btk lo and BLNK +/± B cells (Fig. 5B) . This impairment was more severe when the dosage of both Btk and BLNK was reduced.
BCR-induced proliferation requires activation of the ERK pathway (64) . The role of the B cell signalosome in this process is controversial. While BCR-stimulated ERK activation is normal in B cells from both Btk ±/± (58) and BLNK ±/± mice (16), it is reduced in Btk ±/± DT-40 cells (27) and completely impaired in BLNK ±/± DT-40 cells (9) . To determine whether these contradictory results stem from the relative immaturity of B cells from Btk ±/± and BLNK ±/± mice and/or a redundant function of BLNK and Btk in this pathway in murine cells, we assessed ERK activation in wild-type and BLNK +/± Btk lo B cells (Fig. 5C ). BCR-stimulated ERK phosphorylation was unimpaired in BLNK +/± Btk lo B cells. Thus, the B cell signalosome does not contribute signi®cantly to the activation of this pathway in mature mouse B cells.
Discussion
The present study demonstrates that Btk and BLNK are limiting components of a common signaling pathway that mediates mitogenic signals from the BCR in mature B cells. The functional consequences of their interaction can be observed at both the cellular and molecular level. These studies emphasize the utility of gene dosage/compound heterozygote analysis to delineate mammalian signaling pathways both genetically and biochemically. A similar strategy has recently been used by others to demonstrate interactions among signaling molecules in other B cell processes, including the regulation of early B lymphopoiesis by helix-loop-helix transcription factors (65, 66) , and the inhibition of BCR signals by CD22, Lyn and SH2 domaincontaining tyrosine phosphatase 1 (67) .
Reduced dosage of BLNK alone had signi®cant effects on many of the aspects of the B cell response to BCR crosslinking measured here. Recently, Gong et al. demonstrated that a heterozygous mutation in the adaptor protein Grb2 leads to attenuated TCR-induced activation of JNK and p38, but not ERK (68) . This results in impaired negative selection during thymocyte development. Clearly, even subtle changes in the stoichiometry of linker proteins relative to other components of the signaling complexes they nucleate can have signi®cant effects on the consequences of those signals. Regulated expression of such limiting signaling molecules may be a major mechanism for modulating signal outcome (69) . Indeed, increased expression of several signalosome components is correlated with a reduced threshold for BCR stimulation and a unique pattern of BCR-induced gene expression in immature B cells (45, 70) .
Failure to induce expression of A1, bcl-x L and cyclin D2, which regulate cell survival and cell cycle entry, would be suf®cient to explain the impaired proliferation and survival of BLNK +/± Btk lo cells upon antigen stimulation. A1 and cyclin D2 are likely critical components of Btk signaling pathways as the xid phenotype is rescued only partially by transgenes expressing bcl-x L (51) or bcl-2 (71). It is probable that the B cell signalosome regulates A1, bcl-x L and cyclin D2 expression via its effects on BCR-induced Ca 2+¯u x and/or NF-kB activation (14, 54,57,59±63) (Fig. 5) . Interestingly, the effect of reducing Btk and BLNK levels on BCR-induced Ca 2+¯u x (Fig. 5 ) was subtler than that observed for expression of A1, bcl-x L and cyclin D2 (Fig. 4) . It is possible that small changes in early signaling events, such as Ca 2+¯u x, are ampli®ed into larger effects on more downstream processes, such as transcriptional responses. Alternatively, Btk and/or BLNK may regulate gene expression by Ca 2+ -independent mechanisms as well. These are unlikely to involve the Ras/ERK pathway, however, as we saw no difference between wild-type and BLNK +/± Btk lo B cells with respect to ERK activation (Fig. 5) . The con¯icting results regarding the requirement for B cell signalosome components in BCR-stimulated ERK activation in primary murine cells (16, 58) versus chicken DT-40 cells (9, 27) may be due to species-speci®c effects, differences between primary resting cells and continuously proliferating cell lines or differences in the maturation state of the cells examined.
A tonic BCR signal is required for the maintenance of the mature peripheral B cell population (72) . The presence of normal numbers of IgM lo IgD hi mature B cells indicates that this signal is intact and exceeds a minimal threshold in BLNK +/± Btk lo mice. BCR-initiated activation and proliferation of mature B cells is thus signi®cantly more sensitive to subtle changes in Btk/BLNK signal strength than is BCR-mediated B cell development and homeostasis. Alternatively, Btk and BLNK may function in concert to control the activation of mature B cells but independently to regulate their development and/or survival. These studies also demonstrate that signals regulating the maintenance of mature B cell numbers are independent of the ability of the BCR to induce A1, bcl-x L and cyclin D2. Consistent with these observations, mice lacking either c-rel (73) , which is required for bcl-x L (61) and A1 (14) expression, or cyclin D2 (74, 75) have normal B cell development but, impaired mitogenic responses to BCR cross-linking. Further studies are warranted to de®ne the Btk/BLNK mediated signaling events governing the immature to mature B cell transition.
Loss of Btk function results in the B cell immunode®ciency XLA in humans (38, 39) . The severity of disease in XLA differs signi®cantly with genetic background (76) . More than onethird of the alterations in Btk associated with XLA are missense or other in-frame mutations (77) . Many of these are likely to have some residual function, behaving as weak alleles analogous to the Btk lo transgene. Polymorphisms resulting in subtle changes in the expression level or activity of components of Btk signaling pathways may be clinically insigni®cant on their own, but lead to severe XLA in individuals carrying partial loss of function mutations in Btk. 
